
Triolmewyn 40mg/5mg/12.5mg Tablet
Marketer
Wynclark Pharmaceuticals Private Limited
Salt Composition
Olmesartan Medoxomil (40mg) + Amlodipine (5mg) + Hydrochlorothiazide (12.5mg)
Overview Triolmewyn 40mg/5mg/12.5mg Tablet
Tenexol 40mg/5mg/12.5mg tablets combine multiple medications to effectively manage hypertension when monotherapy proves insufficient. This formulation reduces elevated blood pressure, consequently lowering the risk of stroke and myocardial infarction. Tenexol 40mg/5mg/12.5mg tablets may be taken with or without food, with dosage tailored to individual response and health status. Consistent daily timing is recommended. Continuous use, as directed by your physician, is crucial; discontinuation increases stroke and heart attack risk. Containing a diuretic, increased urination is expected; therefore, avoid administration within four hours of bedtime. Regular use maximizes therapeutic benefits, even during asymptomatic periods, as hypertension often lacks noticeable symptoms. Common side effects include edema in the ankles, cephalalgia, vertigo, fatigue, and altered taste perception. Report persistent, worsening, or bothersome side effects to your doctor. Adequate hydration is vital to mitigate potential side effects like myalgia, xerostomia, and polydipsia. Prior to initiating treatment, disclose any renal or hepatic impairment. Pregnant or lactating individuals should seek medical guidance before use. Inform your doctor of all concurrent medications, particularly those for cardiovascular conditions or hypertension. Regular monitoring of blood pressure, renal function, electrolyte balance, and glycemia is essential to ensure optimal therapeutic efficacy.
Uses of Triolmewyn 40mg/5mg/12.5mg Tablet
Elevated arterial blood pressure
Major Benefits of Triolmewyn 40mg/5mg/12.5mg Tablet:
Administer this medication precisely as prescribed by your physician, adhering to the specified dosage and treatment period. Ingest the Triolmewyn 40mg/5mg/12.5mg Tablet whole; avoid chewing, crushing, or fracturing. Consumption may coincide with meals or be taken independently, however, consistent daily timing is recommended.
Common Side effects of Triolmewyn 40mg/5mg/12.5mg Tablet:
- Headache
- Dizziness
- Nausea
- Upper respiratory tract infection
- Fatigue
- Urinary tract infection
- Diarrhea
- Joint swelling
- Peripheral edema
- Nasopharyngitis (inflammation of the throat and nasal passages)
- Muscle spasm
- Hypotension (low blood pressure)
- Increased creatinine level in blood
- Increased blood urea
- Increased uric acid level in blood
How to use Triolmewyn 40mg/5mg/12.5mg Tablet:
Follow your physician's instructions precisely regarding dosage and treatment length for Triolmewyn 40mg/5mg/12.5mg Tablets. Ingest the tablets whole; avoid crushing, chewing, or breaking them. Consumption may coincide with meals or not, but consistent timing is recommended.
How Triolmewyn 40mg/5mg/12.5mg Tablet works:
The tablet Triolmewyn (40mg/5mg/12.5mg) unites olmesartan medoxomil, amlodipine, and hydrochlorothiazide to manage hypertension. Olmesartan medoxomil, an angiotensin II receptor antagonist, and amlodipine, a calcium channel blocker, both promote vasodilation, reducing blood pressure. Hydrochlorothiazide, a diuretic, enhances urinary electrolyte and water excretion, contributing to lowered blood pressure via improved circulation and vascular relaxation.
SAFETY ADVICE
AlcoholUNSAFE
Consuming alcohol alongside Triolmewyn 40mg/5mg/12.5mg tablets is not advisable.
PregnancyCONSULT YOUR DOCTOR
Use of Triolmewyn 40mg/5mg/12.5mg tablets is contraindicated during pregnancy due to confirmed fetal risk. In exceptional, life-threatening circumstances, a physician might prescribe it when the potential benefits outweigh the known hazards. Always seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
The use of Triolmewyn 40mg/5mg/12.5mg tablets while breastfeeding is likely inadvisable. Available human data indicate potential transfer of the medication into breast milk, posing a possible risk to the infant.
DrivingUNSAFE
Taking Triolmewyn 40mg/5mg/12.5mg tablets might lead to adverse reactions, potentially impairing driving ability. These reactions can include dizziness, headaches, nausea, or fatigue, all of which can compromise concentration and safe driving.
KidneyCAUTION
Patients with severe kidney impairment should exercise caution when using Triolmewyn 40mg/5mg/12.5mg tablets, as dose modification may be necessary. A physician's consultation is advised. Triolmewyn 40mg/5mg/12.5mg tablets are generally not recommended for individuals with severe kidney disease.
LiverCAUTION
Patients with liver impairment should use Triolmewyn 40mg/5mg/12.5mg tablets cautiously. Dosage modification of Triolmewyn 40mg/5mg/12.5mg tablets may be necessary. Physician consultation is advised.
What if you forget to take Triolmewyn 40mg/5mg/12.5mg Tablet :
Should you forget to take a Triolmewyn 40mg/5mg/12.5mg Tablet, administer it immediately. Nevertheless, if your next scheduled dose is imminent, omit the missed tablet and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Triolmewyn 40mg/5mg/12.5mg Tablet
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Heart |
